Generic placeholder image

Recent Advances in Drug Delivery and Formulation

Editor-in-Chief

ISSN (Print): 2667-3878
ISSN (Online): 2667-3886

Research Article

Differential Drug Release Kinetics from Paclitaxel-Loaded Polydioxanone Membranes and Capsules

Author(s): Smrithi Padmakumar, Merin Mary Varghese and Deepthy Menon*

Volume 16, Issue 3, 2022

Published on: 27 July, 2022

Page: [241 - 252] Pages: 12

DOI: 10.2174/2667387816666220707143330

Price: $65

Abstract

Background: Drug laden implantable systems can provide drug release over several hours to years, which eventually aid in the therapy of both acute and chronic diseases. The present study focuses on a fundamental evaluation of the influence of implant properties such as morphology, architecture, porosity, surface area, and wettability in regulating the drug release kinetics from drug-loaded polymeric matrices.

Methods: For this, Polydioxanone (PDS) was selected as the polymer and Paclitaxel (Ptx) as the model drug. Two different forms of the matrix implants, viz., reservoir type capsules developed by dip coating and matrix type membranes fabricated by phase inversion and electrospinning, were utilized for the study. Drug release from all the four different matrices prepared by simple techniques was evaluated in vitro in PBS and ex vivo in peritoneal wash fluid for ~4 weeks. The drug release profiles were thereafter correlated with the physicochemical parameters of the polymeric implants.

Results: Reservoir-type capsules followed a slow and steady zero-order kinetics, while matrix-type electrospun and phase inversion membranes displayed typical biphasic kinetics.

Conclusion: It was inferred that the slow degradation rate of PDS polymer as well as the implant properties like porosity and wettability play an important role in controlling the drug release rates.

Keywords: Biodegradable polymers, matrix or reservoir-type implants, controlled drug delivery, drug release kinetics, polydioxanone, paclitaxel, electrospinning.

Graphical Abstract
[1]
Blackshear PJ. Implantable drug-delivery systems. Sci Am 1979; 241(6): 66-73.
[http://dx.doi.org/10.1038/scientificamerican1279-66]
[2]
Padmakumar S, Parayath N, Leslie F, Nair SV, Menon D, Amiji MM. Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices. Taylor & Francis 2018; p. 15.
[http://dx.doi.org/10.1080/17425247.2018.1446938]
[3]
Rajgor N, Bhaskar V, Patel M. Implantable drug delivery systems: An overview. Syst Rev Pharm 2011; 2(2): 91.
[http://dx.doi.org/10.4103/0975-8453.86297]
[4]
Mohammad Zaki AJ, Patil SK, Baviskar DT, Jain DK. Implantable drug delivery system: A review. Int J Pharm Tech Res 2012; 4(1): 280-92.
[5]
Nitsch MJ, Banakar UV. Implantable drug delivery. J Biomater Appl 1994; 8(3): 247-84.
[http://dx.doi.org/10.1177/088532829400800305] [PMID: 8176637]
[6]
Yang W-W, Pierstorff E. Reservoir-based polymer drug delivery systems. J Lab Autom 2012; 17(1): 50-8.
[http://dx.doi.org/10.1177/2211068211428189] [PMID: 22357608]
[7]
Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci, B, Polym Phys 2011; 49(12): 832-64.
[http://dx.doi.org/10.1002/polb.22259] [PMID: 21769165]
[8]
Justinger C, Slotta JE, Ningel S, Gräber S, Kollmar O, Schilling MK. Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures: Results of a randomized clinical pathway facilitated trial (NCT00998907). Surg (United States) 2013; 154(3): 589-95.
[http://dx.doi.org/10.1016/j.surg.2013.04.011] [PMID: 23859304]
[9]
Brunetti J, Pillozzi S, Falciani C, et al. Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug. Sci Rep 2015; 5(1): 17736.
[http://dx.doi.org/10.1038/srep17736] [PMID: 26626158]
[10]
Padmakumar S, Paul-Prasanth B, Pavithran K, et al. Long-term drug delivery using implantable electrospun woven polymeric nanotextiles. Nanomedicine 2019; 15(1): 274-84.
[http://dx.doi.org/10.1016/j.nano.2018.10.002] [PMID: 30343013]
[11]
Padmakumar S, Parayath NN, Nair SV, Menon D, Amiji MM. Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants. J Control Release 2019; 305: 29-40.
[http://dx.doi.org/10.1016/j.jconrel.2019.05.022] [PMID: 31103675]
[12]
Xiang A, Ma D, Mchugh AJ. The interplay of phase inversion, polymer membrane formation, and drug release in a membrane-based delivery system. J Membr Sci 2010; 358(1-2): 85-92.
[http://dx.doi.org/10.1016/j.memsci.2010.04.031]
[13]
Xie J, Wang CH. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res 2006; 23(8): 1817-26.
[http://dx.doi.org/10.1007/s11095-006-9036-z] [PMID: 16841195]
[14]
Ramachandran R, Junnuthula VR, Gowd GS, et al. Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma. Sci Rep 2017; 7(1): 43271.
[http://dx.doi.org/10.1038/srep43271] [PMID: 28262735]
[15]
Prabaharan M, Jayakumar R, Nair SV. Electrospun Nanofibrous Scaffolds-Current Status and Prospects in Drug Delivery 2011; 2012: 241-62.
[http://dx.doi.org/10.1007/12]
[16]
Zhang Y, Huo M, Zhou J, et al. DDSolver: An add-in program for modeling and comparison of drug dissolution profiles. AAPS J 2010; 12(3): 263-71.
[http://dx.doi.org/10.1208/s12248-010-9185-1] [PMID: 20373062]
[17]
Padmakumar S, Menon D. Nanofibrous polydioxanone depots for prolonged intraperitoneal paclitaxel delivery. Curr Drug Deliv 2019; 16(7): 654-62.
[http://dx.doi.org/10.2174/1567201816666190816102949] [PMID: 31418659]
[18]
Hussein Kamareddine M, Ghosn Y, Tawk A, et al. Organic nanoparticles as drug delivery systems and their potential role in the treatment of chronic myeloid leukemia. Technol Cancer Res Treat 2019; 18: 1533033819879902.
[http://dx.doi.org/10.1177/1533033819879902] [PMID: 31865865]
[19]
Spirescu VA, Chircov C, Grumezescu AM, Vasile B. Ș, Andronescu E Inorganic nanoparticles and composite films for antimicrobial therapies Int J Mol Sci 2021; 22(9): 4595.
[http://dx.doi.org/10.3390/ijms22094595] [PMID: 33925617]
[20]
Chan M-H, Chang Z-X, Huang CF, Lee LJ, Liu R-S, Hsiao M. Integrated therapy platform of exosomal system: Hybrid inorganic/organic nanoparticles with exosomes for cancer treatment. Nanoscale Horiz 2022; 7(4): 352-67.
[http://dx.doi.org/10.1039/D1NH00637A] [PMID: 35043812]
[21]
Uyen NTT, Hamid ZAA, Tram NXT, Ahmad N. Fabrication of alginate microspheres for drug delivery: A review. Int J Biol Macromol 2020; 153: 1035-46.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.10.233] [PMID: 31794824]
[22]
Lee Y, Thompson DH. Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017; 9(5): e1450.
[http://dx.doi.org/10.1002/wnan.1450] [PMID: 28198148]
[23]
Padmakumar S, Jones G, Pawar G, et al. Minimally Invasive Nasal Depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain. J Control Release 2021; 331(331): 176-86.
[http://dx.doi.org/10.1016/j.jconrel.2021.01.027] [PMID: 33484777]
[24]
Park S, Han U, Choi D, Hong J. Layer-by-layer assembled polymeric thin films as prospective drug delivery carriers: Design and applications. Biomater Res 2018; 22(1): 29.
[http://dx.doi.org/10.1186/s40824-018-0139-5] [PMID: 30275972]
[25]
Maver T, Mohan T, Gradišnik L, Finšgar M, Stana Kleinschek K, Maver U. Polysaccharide thin solid films for analgesic drug delivery and growth of human skin cells. Front Chem 2019; 7: 217.
[http://dx.doi.org/10.3389/fchem.2019.00217] [PMID: 31024901]
[26]
Ye H, Tanenbaum LM, Na YJ, et al. Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models. J Control Release 2015; 220(Pt A): 358-67.
[http://dx.doi.org/10.1016/j.jconrel.2015.11.001] [PMID: 26548976]
[27]
Ruirui Z, He J, Xu X, et al. PLGA-based drug delivery system for combined therapy of cancer: Research progress. Mater Res Express 2021; 8(12): 122002.
[http://dx.doi.org/10.1088/2053-1591/ac3f5e]
[28]
Villarruel Mendoza LA, Scilletta NA, Bellino MG, Desimone MF, Catalano PN. Recent advances in micro-electro-mechanical devices for controlled drug release applications. Front Bioeng Biotechnol 2020; 8: 827.
[http://dx.doi.org/10.3389/fbioe.2020.00827] [PMID: 32850709]
[29]
Gai M, Frueh J, Tao T, et al. Polylactic acid nano- and microchamber arrays for encapsulation of small hydrophilic molecules featuring drug release via high intensity focused ultrasound. Nanoscale 2017; 9(21): 7063-70.
[http://dx.doi.org/10.1039/C7NR01841J] [PMID: 28513733]
[30]
Gai M, Kurochkin MA, Li D, et al. In-situ NIR-laser mediated bioactive substance delivery to single cell for EGFP expression based on biocompatible microchamber-arrays. J Control Release 2018; 276: 84-92.
[http://dx.doi.org/10.1016/j.jconrel.2018.02.044] [PMID: 29501723]
[31]
Freag MS, Saleh WM, Abdallah OY. Exploiting polymer blending approach for fabrication of buccal chitosan-based composite sponges with augmented mucoadhesive characteristics. Eur J Pharm Sci 2018; 120: 10-9.
[http://dx.doi.org/10.1016/j.ejps.2018.04.041] [PMID: 29715500]
[32]
Calori IR, Braga G, de Jesus P, Bi H, Tedesco AC. Polymer scaffolds as drug delivery systems. Eur Polym J 2019; 2020(129): 109621.
[http://dx.doi.org/10.1016/j.eurpolymj.2020.109621]
[33]
Liu Z, Huang Y, Zhang X, et al. Fabrication of cyclic brush copolymers with heterogeneous amphiphilic polymer brushes for controlled drug release. Macromolecules 2018; 51(19): 7672-9.
[http://dx.doi.org/10.1021/acs.macromol.8b00950]
[34]
Pan C, Zhou Z, Yu X. Coatings as the useful drug delivery system for the prevention of implant-related infections. J Orthop Surg Res 2018; 13(1): 220.
[http://dx.doi.org/10.1186/s13018-018-0930-y] [PMID: 30176886]
[35]
Han D, Steckl AJ. Coaxial electrospinning formation of complex polymer fibers and their applications. ChemPlusChem 2019; 84(10): 1453-97.
[http://dx.doi.org/10.1002/cplu.201900281] [PMID: 31943926]
[36]
Naseem K, Begum R, Weitai Irfan W, Ahmad Farooqi ZH. Advancement in multi-functional Poly(Styrene)-Poly(N-Isopropylacrylamide) based core shell polymer microgels and their applications. Polym Rev (Phila Pa) 2018; 58(2): 288-325.
[http://dx.doi.org/10.1080/15583724.2017.1423326]
[37]
Ghasemiyeh P, Mohammadi-Samani S. Polymers blending as release modulating tool in drug delivery. Front Mater 2021; 8: 1-12.
[http://dx.doi.org/10.3389/fmats.2021.752813]
[38]
Stewart SA, Domínguez-Robles J, McIlorum VJ, et al. Development of a biodegradable subcutaneous implant for prolonged drug delivery using 3D printing. Pharmaceutics 2020; 12(2): 105.
[http://dx.doi.org/10.3390/pharmaceutics12020105] [PMID: 32013052]
[39]
Domsta V, Seidlitz A. 3D-printing of drug-eluting implants: An overview of the current developments described in the literature. Molecules 2021; 26(13): 4066.
[http://dx.doi.org/10.3390/molecules26134066] [PMID: 34279405]
[40]
Guillen GR, Pan Y, Li M, Hoek EMV. Preparation and characterization of membranes formed by nonsolvent induced phase separation. A review. Ind Eng Chem Res 2011; 2011: 3798-817.
[41]
Young T-H, Hsieh C-C, Chen L-Y, Huang Y-S. The formation mechanism of membranes prepared from the crystalline\rEVAL polymer±water (nonsolvent)±2-propanol (nonsolvent) system. J Membr Sci 1999; 159(1-2): 21-7.
[http://dx.doi.org/10.1016/S0376-7388(99)00038-1]
[42]
Buonomenna MG, Choi S, Galiano F, Drioli E. Membranes prepared via phase inversion. Wiley Online Library 2011.
[http://dx.doi.org/10.1002/9780470977569.ch21]
[43]
Hiremath JG, Khamar NS, Palavalli SG, Rudani CG, Aitha R, Mura P. Paclitaxel loaded carrier based biodegradable polymeric implants: Preparation and in vitro characterization. Saudi Pharm J 2013; 21(1): 85-91.
[http://dx.doi.org/10.1016/j.jsps.2011.12.002] [PMID: 23960822]
[44]
Yang KK, Wang XL, Wang YZ. Poly(p-Dioxanone) and its copolymers. J Macromol Sci Part C Polym Rev 2002; 42(3): 373-98.
[http://dx.doi.org/10.1081/MC-120006453]
[45]
Eva M. Influence of the surface morphology at specific surface area of microfibres made from poly. L-Lactide. NanoCon 2015; 2015: 2-7.
[46]
Rnjak-Kovacina J, Weiss AS. Increasing the pore size of electrospun scaffolds. Tissue Eng Part B Rev 2011; 17(5): 365-72.
[http://dx.doi.org/10.1089/ten.teb.2011.0235] [PMID: 21815802]
[47]
Aluigi A, Varesano A, Montarsolo A, et al. Electrospinning of keratin/poly(ethylene oxide) blend nanofibers. J Appl Polym Sci 2007; 104(2): 863-70.
[http://dx.doi.org/10.1002/app.25623]
[48]
Menzies KL, Jones L. Impact of contact angle on the biocompatibility of biomaterials 2010; 87(6): 387-99.
[49]
McPartland TJ, Patil RA, Malone MF, Roberts SC. Liquid-liquid extraction for recovery of paclitaxel from plant cell culture: Solvent evaluation and use of extractants for partitioning and selectivity. Biotechnol Prog 2012; 28(4): 990-7.
[http://dx.doi.org/10.1002/btpr.1562] [PMID: 22581674]
[50]
Wang N, Burugapalli K, Song W, et al. Tailored fibro-porous structure of electrospun polyurethane membranes, their size-dependent properties and trans-membrane glucose diffusion. J Membr Sci 2013; 427: 207-17.
[http://dx.doi.org/10.1016/j.memsci.2012.09.052] [PMID: 23170040]
[51]
Taylor P, Francis L, Maab H, et al. Desalination and water treatment fabrication of electrospun nanofibrous membranes for membrane distillation application. Desalination Water Treat 2013; 2013: 37-41.
[http://dx.doi.org/10.1080/19443994.2012.700037]
[52]
Raval A, Parikh J, Engineer C. Mechanism of controlled release kinetics from medical devices. Braz J Chem Eng 2010; 27(2): 211-25.
[http://dx.doi.org/10.1590/S0104-66322010000200001]
[53]
Sabino MA, González S, Márquez L, Feijoo JL. Study of the hydrolytic degradation of polydioxanone PPDX. Polym Degrad Stabil 2000; 69(2): 209-16.
[http://dx.doi.org/10.1016/S0141-3910(00)00062-8]
[54]
Okuda T, Tominaga K, Kidoaki S. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes. J Control Release 2010; 143(2): 258-64.
[http://dx.doi.org/10.1016/j.jconrel.2009.12.029] [PMID: 20074599]
[55]
Mohammadian F, Eatemadi A. Drug loading and delivery using nanofibers scaffolds. Artif Cells Nanomed Biotechnol 2017; 45(5): 881-8.
[http://dx.doi.org/10.1080/21691401.2016.1185726] [PMID: 27188394]
[56]
Nieminen HJ, Laidmäe I, Salmi A, et al. Ultrasound-enhanced electrospinning. Sci Rep 2018; 8(1): 4437.
[http://dx.doi.org/10.1038/s41598-018-22124-z] [PMID: 29535342]
[57]
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13(2): 123-33.
[http://dx.doi.org/10.1016/S0928-0987(01)00095-1] [PMID: 11297896]
[58]
Tort S, Han D, Steckl AJ. Self-inflating floating nanofiber membranes for controlled drug delivery. Int J Pharm 2020; 579: 119164.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119164] [PMID: 32081796]
[59]
Pawar HA, Dhavale R. Development and evaluation of gastroretentive floating tablets of an antidepressant drug by thermoplastic granulation technique. Beni Suef Univ J Basic Appl Sci 2014; 3(2): 122-32.
[http://dx.doi.org/10.1016/j.bjbas.2014.05.005]
[60]
Huo P, Han X, Zhang W, Zhang J, Kumar P, Liu B. Electrospun nanofibers of polycaprolactone/collagen as a sustained-release drug delivery system for artemisinin. Pharmaceutics 2021; 13(8): 1228.
[http://dx.doi.org/10.3390/pharmaceutics13081228] [PMID: 34452189]
[61]
Ulker Turan C, Guvenilir Y. Electrospun poly(ω-pentadecalactone-co-ε-caprolactone)/gelatin/chitosan ternary nanofibers with antibacterial activity for treatment of skin infections. Eur J Pharm Sci 2022; 170: 106113.
[http://dx.doi.org/10.1016/j.ejps.2021.106113] [PMID: 34986416]
[62]
Huang WY, Hibino T, Suye SI, Fujita S. Electrospun collagen core/poly-l-lactic acid shell nanofibers for prolonged release of hydrophilic drug. RSC Advances 2021; 11(10): 5703-11.
[http://dx.doi.org/10.1039/D0RA08353D] [PMID: 35423091]
[63]
Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001; 73(2-3): 121-36.
[http://dx.doi.org/10.1016/S0168-3659(01)00248-6] [PMID: 11516493]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy